OptimizeRx
OPRX
#8756
Rank
A$0.20 B
Marketcap
$11.05
Share price
-2.52%
Change (1 day)
-45.86%
Change (1 year)

P/E ratio for OptimizeRx (OPRX)

P/E ratio as of March 2025 (TTM): -8.78

According to OptimizeRx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.78049. At the end of 2022 the company had a P/E ratio of -26.7.

P/E ratio history for OptimizeRx from 2008 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-26.7-100.53%
2021> 1000-2538.34%
2020-208343.9%
2019-46.8-108.53%
2018549-2662%
2017-21.432.15%
2016-16.2-72.01%
2015-57.9145.28%
2014-23.6-86.12%
2013-170541.51%
2012-26.5346.63%
2011-5.938.54%
2010-5.478.16%
2009-5.05-52.39%
2008-10.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-7.30-16.92%๐Ÿ‡บ๐Ÿ‡ธ USA
39.2-546.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.7860-91.05%๐Ÿ‡บ๐Ÿ‡ธ USA
598-6,910.55%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.